National Stock Number
6810-00-975-2503
National Stock Number (NSN) 6810-00-975-2503, or NIIN 009752503, (ammonium citrate,dibasic) was assigned January 1, 1962 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There is only one manufacturer part number associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Aug 09, 2008, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. The Government physically does not have in its possession sufficient, accurate, or legible data to purchase this part from other than current source(s). (NOTE: This code is applicable only to parts under immediate buy requirements and only as long as the deficiency is under review for resolution and appropriate recoding.) Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 23453. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Information is in the Hazardous Materials Information Resource System (HMIRS). NSN 6810009752503 does not contain precious metals.
This NSN is associated to Schedule B 3003100000: medicaments (exclud goods of 3002, 3005, or 3006) containg penicillins or derivatives thereof,or streptomycins or their derivatives. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325411: medicinal and botanical manufacturing.
This information was last updated on Jul 01, 2025.